Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : SALI-10
Therapeutic Area : Dental and Oral Health
Study Phase : Phase I
Sponsor : Natural Products Canada
Deal Size : $1.0 million
Deal Type : Financing
Ostia Sciences Completes $1.46M Seed Round to Develop Microbiome Therapeutics Platform
Details : The funding supports the advancement of their phosphorylated lantibiotic-producing probiotic technology, particularly their lead candidate SALI-10, toward clinical trials for oral health.
Product Name : SALI-10
Product Type : Probiotic
Upfront Cash : Undisclosed
July 18, 2025
Lead Product(s) : SALI-10
Therapeutic Area : Dental and Oral Health
Highest Development Status : Phase I
Sponsor : Natural Products Canada
Deal Size : $1.0 million
Deal Type : Financing
Reset All
